Conference will focus on the following topics during presentations of the three day event, which reflect current research, developments and innovations internationally and as evidenced in both Proteomics and Bioinformatics.

The Proteomics along with bioinformatics has a strong emphasis on support and inspiration for the next generation of scientists, along with early-career researchers, a Young Researchers Forum, and activities to encourage interaction with peers and experts.

Altogether the Conference aims to be an exemplary cross-discipline gathering in the proteomics and bioinformatics life sciences for research presentation, discussion, learning, inspiration and encouragement with participants leaving with new research knowledge and ideas, and perhaps the beginnings of international collaborations and friendships.

• Proteomics & Computational Biology

• Cancer & Clinical proteomics

• Protein Biochemistry • Cardiovascular Proteomics

• Proteomics for Bioinformatics

• Mass Spectrometry Proteomics

• Protein Engineering & Molecular Design

• Immunoproteomics

Scientific Sessions:

Track: 1 Protein Expression & Analysis

Protein expression refers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins. Protein analysis is the bioinformatics study of protein structure, protein interaction and function using database searches, sequence comparisons, structural and functional predictions.

The field of proteomics, particularly the application of mass spectrometry analysis to protein samples, is well-established and growing rapidly. Proteomics studies generate large volumes of raw experimental data and inferred biological results. To facilitate the dissemination of these data, centralized data repositories have been developed that make the data and results accessible to proteomics researchers and biologists alike. This review of proteomics data repositories focuses exclusively on freely-available, centralized data resources that disseminate or store experimental mass spectrometry data and results.

Mass spectrometry (MS) – based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. At the moment, however, the routinely usage of MS-based proteomics is prevented and complicated by the very complex work flow comprising sample preparation, chromatography, MS measurement followed by data processing and evaluation. The new technologies, products and assays developed by Precision Proteomics could help enabling and establishing mass spectrometry (MS) – based proteomics in academic and pharmaceutical research as well as in clinical diagnostics.

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, the proteins are also affected. When pathogens infect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells – from the metabolization of simple sugar to the division of cells – is dependent on proteins for smooth operation. In general, proteomics seeks to detect and quantify as many proteins as possible.

Genomics is a forum for describing the development of genome-scale technologies and their application to all areas of biological investigation. Advances in genomics have triggered a revolution in discovery-based research to understand even the most complex biological systems such as the brain. The field includes efforts to determine the entire DNA sequence of organisms and fine-scale genetic mapping.

Proteins provide most of the molecular machinery of cells. Many are enzymes or subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. Each protein is linear polymers built of amino acids.

Precision proteomics aims to develop innovative technologies for clinical diagnostics in the field of personalized medicine, which should enable the customization of healthcare, tailored to the individual patient using molecular analysis and employing accurate measurements of parameters like proteins from cells or body fluids like blood plasma and urine.

The Changes in the cardiovascular system arise from or have the potential to alter, collectively or individually, proteomes of cardiac muscle and components of the vascular system, including smooth muscle and endothelial cells. Such changes may be documented through an integrated series of proteomic approaches. Traditional proteomics methods of mapping and identifying proteins give researchers the ability to develop protein databases. Global changes may be identified by protein profiling by comparison to either experimental controls or protein databases or both.

Bioinformatics is both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis “pipelines” that are repeatedly used, particularly in the fields of genetics and genomics. Common uses of bioinformatics include the identification of candidate genes and nucleotides.

Proteomics has become an essential tool for understanding biological systems processes at the molecular level. Plant Proteomics publishes novel and significant research in the field of proteomics that examine the dynamics, functions, and interactions of proteins from plant systems.

Unlike other ‘omics’ technologies (genomics, proteomics…etc), proteomics gives organic understanding that mirrors an individual’s one of a kind hereditary unique mark, as well as way of life, eating routine and environment. Utilizing proteomics, scientists can quantitatively dissect non-hereditary variables that are included in postgenomic and posttranscriptional change. Nutritional proteomics is quickly developing to utilize little atom substance profiling to bolster incorporation of eating regimen and sustenance in complex biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. The University of Michigan Nutrition Obesity Research Center (UM NORC) started in 2010, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The UM NORC is one of 12 U.S. focuses intended to move and backing translational, multi-disciplinary exploration in heftiness and sustenance, over the continuum of fundamental science to applications in people (solution) and populations (public health).

A large number of genes with diverse normal functions are involved in human cancers. More than 500 genes have been identified as strongly implicated in the process of transforming normal cells to cancer cells. The expression of these genes in normal cells contributes to normal growth, survival and function, whereas dysregulated expression, including overexpression, loss of expression or expression of a defect protein, in cancer cells contributes to ungoverned tumor growth. Altered gene expression can be caused by coarse structural and numerical chromosomal rearrangements, specific gene amplifications, silencing of transcription through methylation and mutations.

Immunoproteomics is and has been used to increase scientific understanding of both autoimmune disease pathology and progression. Using biochemical techniques, gene and ultimately protein expression can be measured with high fidelity. With this information, the biochemical pathways causing pathology in conditions such as multiple sclerosis and Crohn’s disease can potentially be elucidated. Serum antibody identification in particular has proven to be very useful as a diagnostic tool for a number of diseases in modern medicine (in large part due to the relatively high stability of serum antibodies).

Molecular modelling has become a valuable and essential tool to medicinal chemists in the drug design process. Molecular modelling describes the generation, manipulation or representation of three-dimensional structures of molecules and associated physico-chemical properties. It involves a range of computerized techniques based on theoretical chemistry methods and experimental data to predict molecular and biological properties. Structure-based drug discovery is central to the efficient development of therapeutic agents and to the understanding of metabolic processes. The traditional way of drug discovery is the experimental screening of large libraries of chemicals against a biological target (high-throughput screening or HTS) for identifying new lead compounds.

Neuroproteomics and metabolomics is the study of the protein complexes and species that make up the nervous system. These proteins interact to make the neurons connect in such a way to create the intricacies that nervous system is known for.

Transcriptomics is the study of the transcriptome, the complete set of RNA transcripts that are delivered by the genome, under particular circumstances or in a particular cell utilizing high-throughput routines, for example, microarray analysis. The worldwide transcriptomics business sector is relied upon to develop at a CAGR of 13.7% amid the figure time of 2014 to 2019 and is evaluated to be worth $3,773.0 million by 2019. The transcriptomics market has glaringly developed in the previous couple of years essentially because of the expanding mechanical headways in the field of sequencing advances in transcriptomics research. Recent advances in metabolomic measurement technologies have been dramatic; extracting biological insight from complex metabolite profiles remains a challenge, an analytical strategy that uses data obtained from high resolution liquid chromatography–mass spectrometry and a bioinformatics toolset for detecting actively changing metabolic pathways upon external perturbation. RNA-Seq recently developed approach with transcriptome profiling that uses profound sequencing advancements. The National Human Genome Research Institute (NHGRI), which is a piece of the National Institutes of Health (NIH), has partaken in two ventures that made transcriptome assets for scientists around the globe the Mammalian Gene Collection activity and the Mouse Transcriptome Project.

Systems-wide analysis leads to a moreScientific Program comprehensive view of the intricate signaling transduction pathways that proteins engage in and improves the overall understanding of the complex processes supporting the living systems. Over the last two decades, the development of high-throughput analytical methods and tools, such as microarray technologies, capable of rapidly analyzing thousands of protein-functioning and protein-interacting events, has fueled the growth of this important field.

Biomedical sciences are a set of applied sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology of use in healthcare or public health.

A case study is generally a documented study of a specific real-life situation or imagined scenario, used as a training tool in business schools and firms. Students or trainees are required to analyse the prescribed cases and present their interpretations or solutions, supported by the line of reasoning employed and assumptions made. The case study consists of various notes that represent the particular patient. The detail of the particular patient such as laboratory findings, Medical history, Family history, Social history, Physical examination, Treatment plan etc.

Systems biology is a comprehensive quantitative analysis in which all the components of the biological system interact over a period of time. The Systems biology can be elaborated as “Integrative Biology” with the goal of being able to predict de novo biological outcomes. The term Epigenetics refers to the study of changes in the regulation of gene activity and expression that are not very much dependent on a DNA sequence. The Major difference between data generated in epigenomics study and expression study is the utility of the information of probe location in the genome For the Rms deviation of bond length & bond angle Deviation of bond lengths & angles. Ultimately all based on the geometry of small molecules. A survey taken by bcc research shows that The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

Practically about 600 bioinformatics tools were advanced over the past two years, and are being used to facilitate data analysis and its interpretation. Web assistance in bioinformatics provides interfaces that have been developed for an ample array of applications for bioinformatics. The main enhancement derived from the fact that end users do not have to deal with software and database preservation overheads. There are differing software predominant for bioinformatics like open-source, sequence alignment, healthcare, freeware molecular graphics systems, biomedical and molecular mechanics modelling. In more recent advances, the equivalent of an industrial revolution for ontology was pronounced by the apparition of latest technologies representing bio-ontologies.

About Conference

Hence, we welcome you all to be a part of this event to contribute your novel research ideas.

Conference Series LLC would like to take this opportunity to welcome all of you to “8th International Conference on Proteomics & Bioinformatics” which is to be held during May 22-24, 2017 at Osaka, Japan. Through our theme ‘Proteomics & Bioinformatics: Solving Problems in Health and Life Sciences’, the conference will analyze the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.

Proteomics 2017 conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on Protein Expression and Analysis, Database, Mass Spectrometry, Proteomics Discovery And Function, Analytical Proteomics and Genomics, Protein Biochemistry, Personalized Medicine In Proteomics, Cardiovascular Proteomics, Computational and Biology Proteomics, Proteomics for Bioinformatics, Plant Proteomics, Food and Nutritional Proteomics, Cancer and Clinical proteomics, Immunoproteomics, Protein Engineering and Molecular Design, Neuroproteomics & Neurometabolomics and many more.

Conference Series LLC coordinates 1000+ Global events. Every Year across USA, Europe and Asia with backing from 1000 more scientific societies & Publishes 700+ Open access journals which encompass over 100000 eminent personalities, reputed scientists as an editorial board & organizing committee members. Conference Series LLC is recognized by International Congress as well as Convention Association. World Congress and also International conference as momentously captivated by Nobel laureates, International Symposiums & Workshops, Keynote gatherings, Exhibitions and Delegates.

​Proteomics market analysis has its advancement in case of Proteomics equipment’s & technologies this has made enormous progress in past few years, & according to the Market Research, value of proteomics market was $9.3 billion in 2012, & is expected to reach 21.63$ billion by 2018, at a CAGR of 15.1%. Europe accounts for the second-largest share in the world wide proteomics market, in which Spain is one of the leading contributing states. Valencia is considered to be a hot spot for different researches which are carried out in the field of Proteomics. Proteomics attribute to the study of proteomes, but is also used to characterize the techniques used to determine the complete set of proteins of an organism or system, such as protein purification & mass spectrometry.

Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins are also the products of genes, the machinery of the cells within our bodies. When genes are disturbed, the proteins are also effected. When pathogens infect, causing disease these proteins play a major role in signaling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolization of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.

Market Analysis

Glance at Market of Proteomics:

The Global Proteomics business sector to develop at a CAGR of 8.39% over the period 2014-2019. Propels in mass spectrometry have turned into a noteworthy pattern for the development of the business sector as the information gave by these instruments are exceedingly exact and widely utilized for information examination.

Increment popular for customized medications is one of the significant benefactors to the development of the business sector. Customized drugs are created by hereditary make-up of an individual, and today are broadly utilized for treatment of diabetes and diseases, for example, lung tumor.

Statistics which shows growth in importance of Proteomics:

Proteomics Market Worth of $2,100 Million by 2019: New Report by Markets & Markets

Statistics of Industries Associated with Proteomics:

North America was the business sector pioneer with an offer of ~42% of the worldwide business sector, trailed by Europe with an offer of ~38%. The vicinity of an expansive number of expository hardware producers has contributed altogether toward the North American and European proteomics market. Be that as it may, the Asia-Pacific area speaks to a huge development open door for the proteomics market amid the figure time of 2014 to 2019. The APAC business sector is relied upon to develop at a CAGR of 23% amid the gauge period. The development in this business sector is driven by the developing pharmaceutical and biotechnology commercial ventures.

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had total revenue of $ 43.3 Billion in 2013. By 2017, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for proteomics companies, as a high amount of proteomics research is being conducted in the country.

Global Life science Market Share by Country

Major Proteomics Related Associations around the Globe:

Human Proteome Organization

Japan Human Proteome Organisation (Jhupo)

European Proteomics Association (Eupa)

Spanish Proteomics Society– (Seprot)

Netherlands Proteomic Platform (Npp)

Italian Proteomic Association (Itpa)

Portugese Proteomic Association (Rede Procura)

Iranian Proteomic Society

Taiwan Proteomic Society (Tps)

Austrian Proteomics Society

European Proteomics Association

British Mass Spectrometry Society

Belgian Mass Spectrometry Society

Danish Mass Spectrometry Society

Australian and New Zealand Mass Spectrometry Society

Indiana Proteomics Consortium

Proteome Society

European federation of biotechnology

Australasian Proteomics Society

Major Proteomics Related Research Units in Japan:

RIKEN Center for Sustainable Resource Science

Osaka University

University of Tokyo

Kyoto University

University of Tsukuba

Nagoya University

Hokkaido University

University of Tsukuba

Past Conference Report

Proteomics Congress 2016

Conference Series LLC takes a great pride in announcing the “7th International Conference & Expo on Proteomics” (Proteomics Congress 2016) which was held in Rome, Italy, during 24-26 October, 2016.

Proteomics Congress 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme “Proteomics: An atlas of expression”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Proteomics for Bioinformatics, Cancer and Clinical proteomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Marwa Eltoweissy, University of Göttingen, Germany, Dr. Jill Barber, University of Manchester, UK for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Boris Zaslavsky, Cleveland Diagnostics, USA; John F Cipollo, Center for Biologics Evaluation and Research-USFDA, USA; Stefan Kempa, Berlin Institute for Medical Systems Biology – MDC Berlin, Germany; Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series LLC offers its heartfelt appreciation to the exhibitor Leica Microsystems, collaborators MABIC & Human Behaviour Laboratory who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Conference Series LLC congratulates the best poster award winner Dr. Valerie Morineaux, Direction générale de l’Armement, France, Mr. Marlon Henrique e Silva Cardoso, Universidade de Brasília, Brazil and Alena Dmitrievna Volyntceva, Lomonosov Moscow State University, Russia. We would also like to thank Dr. Boris Zaslavsky, Cleveland Diagnostics, USA and Dr. Jill Barber, University of Manchester, UK who supported us by evaluating the posters.

Conference Series LLC 7th International Conference & Expo on Proteomics would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of seven consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Asia pacific is the “8th International Conference on Proteomics and Bioinformatics” which is going to be held during May 22-24, 2017 in Osaka, Japan.